Overview KBroVet®-CA1 has received conditional approval from the FDA for the control of seizures associated with idiopathic epilepsy in dogs.

  • Developed to provide a consistent and reliable source of potassium bromide for veterinary patients
  • Liver-flavored chewable tablets

250 mg

500 mg